Volume 15, Issue 3, Pages (March 2014)

Slides:



Advertisements
Similar presentations
SHP-2 Tyrosine Phosphatase as an Intracellular Target of Helicobacter pylori CagA Protein Hideaki Higashi, Ryouhei Tsutsumi, Syuichi Muto,Toshiro Sugiyama,
Advertisements

and Masanori Hatakeyama
Cellular Senescence What is it? What causes it? Why is it important
AMPK—Sensing Energy while Talking to Other Signaling Pathways
Biology and Treatment of Aggressive Fibromatosis or Desmoid Tumor
Charles Swanton, Julian Downward  Cancer Cell 
promotes the oncogenic activity of CagA
Concept 18.5: Cancer results from genetic changes that affect cell cycle control The gene regulation systems that go wrong during cancer are the very same.
Chap. 16 Problem 1 Cytokine receptors and RTKs both form functional dimers on binding of ligand. Ligand binding activates cytosolic kinase domains which.
The Chromosomal Instability Pathway in Colon Cancer
Inflammation and Colon Cancer
The promise of cancer genetics
Enterococcus faecalis: E. coli’s Siderophore-Inducing Sidekick
A CRTCal Link between Energy and Life Span
K. Lenhard Rudolph, Daniel Hartmann, Oliver G. Opitz  Gastroenterology 
Is Hepatitis C Virus Carcinogenic?
Yorkie and Scalloped: Partners in Growth Activation
Molecular regulation of mast cell activation
Selective estrogen receptor modulation
Development of PI3K/AKT/mTOR Pathway Inhibitors and Their Application in Personalized Therapy for Non–Small-Cell Lung Cancer  Vassiliki Papadimitrakopoulou,
A Sour Relationship between BabA and Lewis b
Volume 61, Issue 2, Pages (August 2014)
The promise of cancer genetics
A Greasy Foothold for Helicobacter pylori
Coordinate Transcriptional Regulation by ERG and Androgen Receptor in Fusion- Positive Prostate Cancers  Yu Chen, Charles L. Sawyers  Cancer Cell  Volume.
Dysregulation of Wnt/β-Catenin Signaling in Gastrointestinal Cancers
PKB Binding Proteins Cell
Volume 36, Issue 1, Pages 2-14 (October 2009)
The Morphogenetic Code and Colon Cancer Development
Volume 119, Issue 3, Pages (September 2000)
Volume 130, Issue 4, Pages (April 2006)
AMPK—Sensing Energy while Talking to Other Signaling Pathways
Robert J. Lefkowitz, Keshava Rajagopal, Erin J. Whalen  Molecular Cell 
Microbes, Microbiota, and Colon Cancer
Inflammation, Atrophy, Gastric Cancer: Connecting the Molecular Dots
T Cells Are Smad’ly in Love with Galectin-9
Volume 9, Issue 6, Pages (June 2011)
Long Noncoding RNA in Hematopoiesis and Immunity
RAS Proteins and Their Regulators in Human Disease
Helicobacter pylori in Health and Disease
AKT/PKB Signaling: Navigating the Network
A New FOXO Pathway Required for Leukemogenesis
Jennifer M. Noto, Richard M. Peek  Cell Host & Microbe 
Inflammation-Associated Cancer Development in Digestive Organs: Mechanisms and Roles for Genetic and Epigenetic Modulation  Tsutomu Chiba, Hiroyuki Marusawa,
Proteins Kinases: Chromatin-Associated Enzymes?
Caspases and Kinases in a Death Grip
Elanor N. Wainwright, Paola Scaffidi  Trends in Cancer 
Autosomal dominant polycystic kidney disease: the last 3 years
Blinded by the Light: The Growing Complexity of p53
Tumor Metabolism: MAGE-A Proteins Help TRIM Turn Over AMPK
The Gastrointestinal Tumor Microenvironment
Ekaterina Pak, Rosalind A. Segal  Developmental Cell 
Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
MYC on the Path to Cancer
Diego Varela, Gerald W. Zamponi  Neuron 
Jeffrey Caplan, Meenu Padmanabhan, Savithramma P. Dinesh-Kumar 
Stressing Out PanIN: NRF2 Pushes over the Edge
Poxviruses Taking a Ride on Actin: New Users of Known Hardware
Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities
Jun-Young Seo, Rakina Yaneva, Peter Cresswell  Cell Host & Microbe 
Mutant BRAF Melanomas—Dependence and Resistance
Friends with Benefits: Microenvironmental NRG1β and HGF Mediate HER2-Targeted Resistance in L-HER2+ and HER2E Breast Cancer  Sarah B. Crist, Cyrus M.
Volume 119, Issue 4, Pages (October 2000)
Discovery of a Secreted Tumor Suppressor Provides a Promising Therapeutic Strategy for Follicular Lymphoma  Marc R. Mansour, A. Thomas Look  Cancer Cell 
Volume 7, Issue 1, Pages 1-11 (July 1997)
Volume 13, Issue 3, Pages (March 2008)
Tenets of PTEN Tumor Suppression
Successful targeting of ErbB2 receptors—is PTEN the key?
The Ups and Downs of Src Regulation: Tumor Suppression by Cbp
Dendritic Tau in Alzheimer’s Disease
Presentation transcript:

Volume 15, Issue 3, Pages 306-316 (March 2014) Helicobacter pylori CagA and Gastric Cancer: A Paradigm for Hit-and-Run Carcinogenesis  Masanori Hatakeyama  Cell Host & Microbe  Volume 15, Issue 3, Pages 306-316 (March 2014) DOI: 10.1016/j.chom.2014.02.008 Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 1 Structural Diversity of H. pylori CagA (A and B) East Asian CagA (A) and Western CagA (B) are respectively characterized by the presence of an EPIYA-D segment and an EPIYA-C segment, to which SHP2 binds in a tyrosine-phosphorylation-dependent manner. In Western CagA species, the EPIYA-C segment duplicates with a variable number, usually one to three times, in tandem. The EPIYA-A and EPIYA-B segments serve as sites for Csk binding upon tyrosine phosphorylation. The CM motif interacts with PAR1. In general, Western CagA contains a single Western CM motif, whereas East Asian CagA possesses at least two Western CM motifs. (C) There are a few CagA variants containing atypical combinations of Western and East Asian CM motifs. Cell Host & Microbe 2014 15, 306-316DOI: (10.1016/j.chom.2014.02.008) Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 2 Coordinated Deregulation of Ras and Wnt Pathways by CagA Membrane-tethered CagA recruits a fraction of cytoplasmic SHP2 to the membrane. CagA-deregulated SHP2 hyperstimulates Ras-Erk signaling. Activated Ras, while inducing a mitogenic signal, promotes nuclear translocalization of cytoplasmic SHP2, which is not bound to CagA. At the membrane, CagA also dissociates β-catenin from E-cadherin and accelerates its nuclear translocalization. In the nucleus, where both SHP2 and β-catenin are forced to accumulate by the action of CagA, SHP2 dephosphorylates parafibromin (PF) and thereby enables the formation of the PF/β-catenin complex, which potentiates the activation of Wnt target genes. Cell Host & Microbe 2014 15, 306-316DOI: (10.1016/j.chom.2014.02.008) Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 3 Flip-Flop Regulation of CagA Activity CagA is delivered into gastric epithelial cells via the H. pylori type IV secretion system, where it acts as an oncogenic scaffold or hub. The CagA protein consists of structured N-terminal and disordered C-terminal regions. Folded N-terminal CagA displays a heretofore unidentified structure with three distinct domains (domains I–III). Domain I (blue) constitutes the N terminus, whereas domain II (yellow) tethers CagA to the inner plasma membrane via the basic patch (green)-phosphatidylserine (pink) interaction. Intramolecular interaction with domain III (red) potentiates binding capability of the disordered C-terminal tail with PAR1 and SHP2, thereby enhancing the oncogenic scaffold or hub function of CagA. Cell Host & Microbe 2014 15, 306-316DOI: (10.1016/j.chom.2014.02.008) Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 4 Hit-and-Run Model of CagA-Mediated Gastric Carcinogenesis Direct pro-oncogenic actions of CagA include (1) aberrant activation of promitogenic signaling pathways, (2) disruption of cell-cell interaction and loss of cell polarity, and (3) inactivation of tumor suppressors such as p53 and RUNX3. In conjunction with chronic inflammation, CagA also induces genetic and epigenetic alterations in the host cells, which, in the long run, compensate pro-oncogenic actions of CagA via secondary alterations, thereby making cells independent of CagA for neoplastic transformation. Loss-of-function mutation of the FAT tumor suppressor homolog 4 (FAT4) gene or the AT-rich interactive domain-containing protein 1A (ARID1A) gene observed in ∼10% of gastric cancer genomes (Zang et al., 2012; Wu and Roberts, 2013) may additionally contribute to gastric carcinogenesis by perturbing tumor suppressor pathways such as pRB or Hippo. Cell Host & Microbe 2014 15, 306-316DOI: (10.1016/j.chom.2014.02.008) Copyright © 2014 Elsevier Inc. Terms and Conditions

Figure 5 Directional Switching of CagA Signaling (A) In early life, injection of CagA into normal gastric epithelial cells elicits oncogenic stress, which induces premature cell senescence or apoptosis. As a result, a reduced number of acid-secreting cells and subsequent increase in gastric pH provide direct merit for H. pylori colonization. By inducing junctional and polarity defects, CagA may also cause chronic gastritis and/or peptic ulceration because of structural disintegration of gastric mucosa. (B) Chronic inflammation associated with long-term cagA-positive H. pylori infection causes genetic and epigenetic instability in the infected stomach mucosa, which markedly enhances the ability of cells to acquire resistance to oncogenic stress by secondary adaptation. Delivery of CagA into such abnormal cells switches the direction of the CagA signal from senescence or apoptosis to unconstraint proliferation, thereby expanding cancer precursor cells in elderly stomach mucosa. Cell Host & Microbe 2014 15, 306-316DOI: (10.1016/j.chom.2014.02.008) Copyright © 2014 Elsevier Inc. Terms and Conditions